Earnings: BioMimetic posts $6.4M Q2 loss
Bizjournals.com - 9 hours ago Franklin-based BioMimetic Therapeutics Inc. (Nasdaq: BMTI) posted a $6.4 million loss, or 23 cents per share, in the second quarter, slightly better than an $8.2 million loss in the year-ago quarter.



More...